EGFR TKIs Combinding the inhibition of RAS-ERK signaling in NSCLC Treatment

EGFR TKIs Combinding the inhibition of RAS-ERK signaling in NSCLC Treatment

Journal of Clinical Research in Oncology
Volume-4
Issue 1

Table of Contents

46
Views
2
Downloads
PDF
XML

Subscribe Newsletter

By subscribing you will get the latest news from us.

Quick Links

Others

Get in touch

Asclepius Open LLC

23191, Wrathall Dr, Ashburn, VA 20148,

USA

Email: support@asclepiusopen.com

© 2024 Asclepius Open LLC